A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo-Reference-Cited by-同舟云学术

A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo

Published:2011-12-12 Issue:1 Volume:42 Page:101-109
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Pantel Austin,Cheong Cheolho,Dandamudi Durga,Shrestha Elina,Mehandru Saurabh,Brane Luke,Ruane Darren,Teixeira Angela,Bozzacco Leonia,Steinman Ralph M.,Longhi M. Paula

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. Vaccine manufacturing: challenges and solutions;Ulmer;Nat. Biotechnol.,2006

2. New adjuvants for human vaccines;Mbow;Curr. Opin. Immunol.,2010

3. Role of adjuvants in modeling the immune response;Carter;Curr. Opin. HIV AIDS,2010

4. Dendritic cells require a systemic type I interferon response to induce CD4+ Th1 immunity with poly IC as adjuvant;Longhi;J. Exp. Med.,2009

5. New horizons in adjuvants for vaccine development;Reed;Trends Immunol.,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors;Human Vaccines & Immunotherapeutics;2024-03-04

2. The recent advancements in protein nanoparticles for immunotherapy;Nanoscale;2024

3. Models of Protective Immunity against Schistosomes: Implications for Vaccine Development;Pathogens;2023-10-03

4. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages;Cancers;2023-09-19

5. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans;Scientific Reports;2023-08-25